• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72SDKIT
Device Problems Fracture (1260); Physical Resistance/Sticking (4012)
Patient Problem Foreign Body In Patient (2687)
Event Date 02/15/2024
Event Type  Injury  
Event Description
The patient was undergoing a thrombectomy procedure in the basilar artery using a penumbra system red72 reperfusion catheter (red72), a sendit delivery device (sendit), a benchmark bmx96 access system (bmx96), and a non-penumbra stent retriever.It should be noted that the patient''s anatomy was tortuous.During the procedure, the stent retriever along with the red72 was advanced to the target location and removed under aspiration three times without successful recanalization of the vessel.While attempting to remove the stent retriever and the red72 on the final attempt, the physician experienced resistance and noticed that the stent retriever and the red72 were fractured.It was reported that the red72 fractured at the distal end.The physician then snared the red72.The fractured stent retriever was left in the body after multiple attempts to remove.The procedure ended at this point.
 
Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.H3 other text : placeholder.
 
Manufacturer Narrative
Evaluation of the returned red72 confirmed a fracture on the distal end and revealed stretching at the fracture site.This type of damage typically occurs due to retraction against resistance.If the red72 is retracted against resistance, it may become stretched and subsequently fracture.The reported tortuous patient''s anatomy may have contributed to the resistance during retraction.Further evaluation of the device revealed multiple kinks both distal and proximal to the fractured location.This damage was likely incidental to the complaint.The kinks distal to the fractured location may have occurred due to advancement against resistance.The kinks proximal to the fractured location likely occurred during packaging for return to penumbra or snaring for removal.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key18890756
MDR Text Key337511296
Report Number3005168196-2024-00078
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00815948025943
UDI-Public815948025943
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211654
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRED72SDKIT
Device Lot NumberF00009297
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/04/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 02/16/2024
Initial Date FDA Received03/12/2024
Supplement Dates Manufacturer Received03/14/2024
Supplement Dates FDA Received04/16/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/11/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age86 YR
Patient SexMale
-
-